|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.090 USD | +1.95% |
|
+5.03% | +16.11% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 08/06/2026 | 09/06/2026 | 10/06/2026 | 11/06/2026 | 12/06/2026 | |
|---|---|---|---|---|---|
| Last | 1.960 $ | 1.980 $ | 1.970 $ | 2.050 $ | 2.090 $ |
| Volume | 454,663 | 460,545 | 360,834 | 603,536 | 254,955 |
| Change | -1.51% | +1.02% | -0.51% | +4.06% | +1.95% |
| Opening | 1.970 $ | 1.960 $ | 1.980 $ | 1.990 $ | 2.070 $ |
| High | 2.020 $ | 2.025 $ | 2.010 $ | 2.075 $ | 2.110 $ |
| Low | 1.945 $ | 1.960 $ | 1.960 $ | 1.970 $ | 2.060 $ |
Performance
| 1 day | +1.95% | ||
| 1 week | +5.03% | ||
| Current month | -0.95% | ||
| 1 month | +9.42% | ||
| 3 months | -25.09% | ||
| 6 months | +16.76% | ||
| Current year | +16.11% | ||
| 1 year | +35.71% | ||
| 3 years | -7.52% | ||
| 5 years | -3.69% | ||
| 10 years | -72.82% |
Volumes
marketsDaily volume
254,955
Estimated daily volume
254,955
Avg. Volume 20 sessions
643,541
Daily volume ratio
0.4
Avg. Volume 20 sessions USD
1,345,000.69
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
168,394,731
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
161,864,727
Average Daily Capital Traded
0.8%
Indicators
Moving average 5 days
1.99
Moving average 20 days
2.018
Moving average 50 days
2.102
Moving average 100 days
2.35
Price spread / (MMA5)
-4.78%
Price spread / (MMA20)
-3.42%
Price spread / (MMA50)
+0.56%
Price spread / (MMA100)
+12.45%
RSI 9 days
55.19
RSI 14 days
50.86
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.95% | +5.03% | +35.71% | -7.52% | 168M | |
| -2.41% | +0.14% | +39.53% | +154.43% | 1,010B | |
| +1.07% | +3.48% | +53.75% | +50.64% | 580B | |
| +1.32% | +0.22% | +18.35% | +65.35% | 402B | |
| +0.77% | 0.00% | +19.99% | +16.80% | 330B | |
| -1.42% | -1.44% | +45.50% | +8.37% | 294B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 280B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 281B | |
| +1.66% | +1.20% | -44.67% | -47.49% | 197B | |
| +0.32% | +1.61% | +19.48% | +63.42% | 192B | |
| Average | -0.06% | +1.09% | +23.42% | +35.22% | 356.72B | |
| Weighted average by Cap. | -0.80% | +1.00% | +29.84% | +66.16% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6206d9043.qOpkJ-47z9xZ-3ysp71NDtEIOs9h2nW2gdCLTKQM7ns.x6YMYqZvi-wggRTV6cUUPIldCbcCtjrd2LmyGs5pgD7wojRs3Vz5nh6vCw
| Date | Price | Volume | Total |
|---|---|---|---|
| 00:00:00 | 2.090 | 23,917 | 201,758 |
| 23:59:56 | 2.090 | 175 | 177,841 |
| 23:59:56 | 2.090 | 200 | 177,666 |
| 23:59:56 | 2.090 | 100 | 177,466 |
| 23:59:52 | 2.085 | 100 | 177,366 |
| 23:59:50 | 2.085 | 498 | 177,266 |
| 23:59:50 | 2.090 | 200 | 176,768 |
| 23:59:49 | 2.085 | 191 | 176,568 |
| 23:59:48 | 2.085 | 900 | 176,377 |
| 23:59:47 | 2.090 | 100 | 175,477 |
Course Extremes
| 1 week | 1.94 |  | 2.11 |
| 1 month | 1.88 | | 2.18 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.32 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +16.11% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
